Adalimumab in childhood inflammatory Bowel disease

被引：0
|
作者：
Noc, J. D. [1 ]
Pfefferkorn, M. D. [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
PEDIATRIC RESEARCH | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
37
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [21] Adalimumab originator and biosimilars in global inflammatory bowel disease treatment
    Yiu, Tsz Hong
    Nakase, Hiroshi
    Leung, Wai Keung
    Lin, Huiyu
    Banerjee, Rupa
    Anderson, Emilia
    Leong, Rupert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 173 - 174
  • [22] Adalimumab for treatment of very early onset inflammatory bowel disease
    Xie Yao
    Liu LiLi
    Jiang Yi
    Tang ZeZhong
    Sun GuoYu
    Hou XinLin
    中华医学杂志英文版, 2019, 132 (23) : 2889 - 2890
  • [23] Update on the management of inflammatory bowel disease: specific role of adalimumab
    Guidi, Luisa
    Pugliese, Daniela
    Armuzzi, Alessandro
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2011, 4 : 163 - 172
  • [24] Adalimumab Persistence for Inflammatory Bowel Disease in Veteran and Insured Cohorts
    Govani, Shail M.
    Lipson, Rachel
    Noureldin, Mohamed
    Wiitala, Wyndy
    Higgins, Peter D. R.
    Saini, Sameer D.
    Pugh, Jacqueline A.
    Velligan, Dawn I.
    Stidham, Ryan W.
    Waljee, Akbar K.
    AMERICAN JOURNAL OF MANAGED CARE, 2018, 24 (12): : E374 - +
  • [25] Efficacy and safety of adalimumab in the treatment of inflammatory bowel disease in children
    De Caro, G.
    Madia, C.
    Gaiani, F.
    Fugazza, A.
    Bizzarri, B.
    Ghiselli, A.
    Fornaroli, F.
    Vincenzi, F.
    de' Angelis, G. L.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S374 - S375
  • [26] Adalimumab Concentrations Following Dose Escalation in Inflammatory Bowel Disease
    Jasurda, Jake
    McCabe, Robert
    Vaughn, Byron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S437 - S438
  • [27] OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE
    Dillon, A.
    Rowan, C.
    Gibson, D.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    GUT, 2013, 62
  • [28] Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical Setting
    Trinder, Matthew W.
    Lawrance, Ian C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) : 1252 - 1257
  • [29] Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
    Kamal, Mahmoud E.
    Werida, Rehab H.
    Radwan, Mahasen A.
    Askar, Safaa R.
    Omran, Gamal A.
    El-Mohamdy, Marwa A.
    Hagag, Radwa S.
    INFLAMMOPHARMACOLOGY, 2024, 32 (05) : 3259 - 3269
  • [30] Effect of Adalimumab on Semen Quality in Inflammatory Bowel Disease Patients
    Zelinkova, Zuzana
    van der Ent, Cokkie
    Kuipers, Ernst J.
    Dohle, Gert R.
    van der Woude, Christien J.
    GASTROENTEROLOGY, 2013, 144 (05) : S411 - S411
12345